Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasmsJoão Agostinho Machado‐Neto, Fabı́ola Traina|Cell Death and Disease|2018Cited by 30
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagyKeli Lima, João Agostinho Machado‐Neto|Blood Cancer Journal|2022Cited by 29
Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasmsKeli Lima, João Agostinho Machado‐Neto|Scientific Reports|2019Cited by 22
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cellsJoão Agostinho Machado‐Neto, Fabı́ola Traina|Oncotarget|2015Cited by 20
Targeting glioma cells by antineoplastic activity of reversineCamila Hirakata, João Agostinho Machado‐Neto|Oncology Letters|2021Cited by 13